We also established a positive correlation between GOLPH3 expression and NSCLC metastasis, thus implicating GOLPH3 as a novel prognostic biomarker or potential therapeutic target for metastasis of NSCLC. This evidence concerns the gene GOLPH3 and non-small cell lung carcinoma.